SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-18-005928
Filing Date
2018-08-09
Accepted
2018-08-09 14:19:43
Documents
47
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_080818p.htm 10-Q 586101
2 EXHIBIT 31.1 exh_311.htm EX-31.1 9054
3 EXHIBIT 31.2 exh_312.htm EX-31.2 9347
4 EXHIBIT 32.1 exh_321.htm EX-32.1 3843
5 EXHIBIT 32.2 exh_322.htm EX-32.2 3764
  Complete submission text file 0001171843-18-005928.txt   4272952

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE bcrx-20180630.xml EX-101.INS 847342
7 XBRL SCHEMA FILE bcrx-20180630.xsd EX-101.SCH 48619
8 XBRL CALCULATION FILE bcrx-20180630_cal.xml EX-101.CAL 34586
9 XBRL DEFINITION FILE bcrx-20180630_def.xml EX-101.DEF 361377
10 XBRL LABEL FILE bcrx-20180630_lab.xml EX-101.LAB 327110
11 XBRL PRESENTATION FILE bcrx-20180630_pre.xml EX-101.PRE 367909
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 181004490
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1